Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

approved   publishing date : 2021 - 06 - 07    save search

Citizens Shareholders Approve Say-On-Pay
Published: 2021-06-07 (Crawled : 21:00) - prnewswire.com
CIA 4 | $2.03 1.0% 0.49% 54K twitter stocktwits trandingview |
Finance
| | O: 0.0% H: 1.37% C: -1.37%

approval
TELUS becomes first national telecom in Canada to set science-based GHG emissions reduction targets approved by STBi
Published: 2021-06-07 (Crawled : 20:00) - globenewswire.com
TIXT | $7.81 -0.13% 0.0% 290K twitter stocktwits trandingview |
| | O: -0.39% H: 1.79% C: 0.75%
TU | $15.92 0.89% 0.0% 1.8M twitter stocktwits trandingview |
Communications
| | O: -0.04% H: 0.26% C: -0.43%


Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Published: 2021-06-07 (Crawled : 19:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.6% C: -0.39%

fda fda approval children approval
FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
Published: 2021-06-07 (Crawled : 18:00) - globenewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 3.22% H: 58.64% C: 34.03%

disease alzheimer treatment fda approval alzheimer’s alzheimer's disease alzheimer's
Synaptogenix Responds to FDA Approval of Aducanumab
Published: 2021-06-07 (Crawled : 16:00) - prnewswire.com
SNPX | $4.33 -7.08% -7.62% 30K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 7.76% H: 26.67% C: -8.67%

fda fda approval approval
FDA Approves First-of-its-Kind SenSight™ Directional Lead System for DBS Therapy
Published: 2021-06-07 (Crawled : 14:00) - biospace.com/
MDT | $79.48 0.37% -0.29% 6.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.6% C: -0.35%

fda therapy fda approval approval
Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union
Published: 2021-06-07 (Crawled : 12:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 9.95% C: 6.02%

covid europe vaccine approval
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.